Attitudes to predictive DNA testing in familial adenomatous polyposis

Journal of Medical Genetics

Volumn 33, Issue 7, 1996, Pages 540-543

  Whitelaw, S ^a,c   Northover, J M ^a   Hodgson, S V ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Law Hospital   (United Kingdom)

Author keywords

Attitude; Familial adenomatous polyposis; Predictive DNA testing

Indexed keywords

DNA;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; ATTITUDE; BIRTH; CLINICAL PRACTICE; DNA DETERMINATION; FAMILY PLANNING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST;

EID: 0030016277     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.33.7.540     Document Type: Article

References (17)

1. Domizio P, Talbot IC, Spigelman AD, Williams CB, Phillips RK. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990;43:738-43.
2. Bussey H, Eyers A, Ritchie S, Thomson J. The rectum in adenomatous polyposis: the St Mark's policy. Br J Surg 1985;72:S29-31.
3. Northover JM, Murday V. Familial colorectal cancer and familial adenomatous polyposis. Bailliercs Clin Gastroenterol 1989;3:593-613.
4. Bulow S. Incidence of associated diseases in familial polyposis coli. Semin Surg Oncol 1987;3:84-7.
5. Nugent K, Spigelman A, Philips R. Life table analysis of death from all causes in familial adenomatous polyposis (FAP) treated by colectomy and ileorectal anastomosis. Leeds Castle Polyposis Group 5th Biennial Meeting, Copenhagen, Denmark, 1993.
6. Polkinghome PJ, Ritchie S, Neale K, Schoeppner G, Thomson JP, Jay BS. Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis. Eye 1990;4:216-21.
7. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
8. Eckert WA, Jung C, Wolff G. Presymptomatic diagnosis in families with adenomatous polyposis using highly polymorphic dinucleotide CA repeat markers flanking the APC gene. J Med Genet 1994;31:442-7.
9. Cottrell S, Bicknell D, Kaklamanis L, Bodmer WF. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet 1992;340:626-30.
10. Beeson D, Globus M. Prenatal testing in hemophilia. Am J Med Genet 1984;20:107-14.
11. Adam S, Wiggins S, Whyte P, et al. Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. J Med Genet 1993;30:549-56.
12. Tibben A, Niermeijer M, Roos R, et al. Understanding the low uptake of presymptomatic DNA testing for Huntington's disease. Lancet 1992;340:1416.
13. Burn J, Chapman P, Delhanty J, et al. The UK Northern Region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet 1991;28:289-96.
14. Meissen G, Berchek R. Intended use of predictive testing by those at risk of Huntington's disease. Am J Med Genet 1987;26:283-93.
15. Bloch M, Hayden M. Opinion. Predictive testing for Huntington's disease in childhood: challenges and implications. Am J Hum Genet 1990;46:1-4.
16. Report of a Working Party of the Clinical Genetics Society. The genetic testing of children. J Med Genet 1994;31:785-97.
17. Friedl W, Caspari R, Piechaczek B, Propping P. Predictive DNA testing in familial adenomatous polyposis. Lancet 1991;337:1172.